Amalgam Rx, the leader in connecting healthcare providers and life sciences companies through a SaaS-enabled digital marketplace and product platform, announced the acquisition of the assets of Geetha, an adaptive, conversational AI company.
The acquisition supports Amalgam’s data science assets, which include more than 6 billion longitudinal data points on millions of patients cared for across Amalgam’s technology platforms.
Newly appointed Chief Data Scientist and Head of AI of Amalgam Rx, Bharath Sudharsan said: “Next-gen AI can deeply understand, empathize, and adapt to each person, almost like a real human friend, with the added benefits of 24/7 availability and expertly curated and safe feedback within a judgment-free space. Every time a patient connects, its rapport, relationship, and level of support can get so much better. When we combine this new AI with Amalgam’s impressive clinical, technology, and regulatory platform/capabilities, it can lead to a deeper level of empathetic engagement, which, in turn can effect lasting change and outcomes.”
